Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #9575
Ace Report Cover Hand & Wrist

AAOS2017: Triamcinonlone has higher rate of resolution for trigger finger vs dexamethasone

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Triamcinolone vs. Dexamethasone Injection for Trigger Finger: A Randomized Controlled Trial

Contributing Authors: S Cassel EA Lawler NA Glass A Shah

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


69 patients with trigger finger were randomized to treatment with either triamcinolone injection or dexamethasone injection. Patients were followed up at 6 weeks, 12 weeks, and 6 months for symptom resolution. Repeat injections were offered in cases of persistent or recurrent symptoms. During follow-up, fewer patients of the triamcinolone group required repeat injection compared to the dexamethaso...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.